Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Use financial data to refine your budget with practical steps that help identify waste and improve allocation. This intro explains a data-driven approach to smarter budgeting.
27,071 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A landmark U.S. refinery plan in Brownsville is unveiled but its first fuel production won’t come for years, leaving ...
This guide breaks down the dynatrace (dt) 2026 earnings narrative for investors. It covers growth drivers, margins, g...
Three nuclear energy stocks that are quietly gaining traction could redefine portfolios in 2026. Explore Fluor, Urani...
SpaceX's market debut ignited a wave of aggressive bets on disruptive ideas. Investors pile into moonshot bets as opt...
Alphabet stock doubled year as the tech giant rode AI optimism and cloud growth. This guide breaks down what happened...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
Regulators have signaled close scrutiny of a possible Paramount-Warner Bros. merger, threatening delays and potential...
Newrez unveils a branded AI mortgage assistant inside ChatGPT to help borrowers explore loan options without initial ...
A wave of AI-driven market chatter claims Sam Altman’s ChatGPT-style model is forecasting a sharp XRP rally over the ...
A federal watchdog report finds a notable denial rate for prior authorizations in Medicare Advantage plans, with wide...
Is Meta Platforms a compelling bargain value, or is the stock trapped in a value trap? This guide breaks down the cas...